SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
Sera Prognostics Inc., known as The Pregnancy Company®, based in Salt Lake City, made a notable move on June 23, 2026, aligning with the increasing emphasis on early detection and handling of the risks associated with preterm birth. As a company listed on Nasdaq under the symbol SERA, they are dedicated to enhancing maternal and neonatal health through cutting-edge pregnancy solutions.
